Vimarsana
Biggest News Aggregation in the World

Page 9 - Optimizerx Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optimizerx Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optimizerx Corp Today - Breaking & Trending Today

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and More - Vimarsana News

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and More

Life sciences organizations and companies strengthen their leadership teams and boards with these Movers & Shakers.

Cramer's Lightning Round: Don't Sell Marvell Technology - Vimarsana News

Cramer's Lightning Round: Don't Sell Marvell Technology

“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.

Physicians Say Access Challenges Impact Their Care Plans for Up to 33% of Patients - Vimarsana News

Physicians Say Access Challenges Impact Their Care Plans for Up to 33% of Patients

Physicians would make a different therapy choice for 33% of patients if medication access was not a factor, and physicians had to change their treatment plan

Related Topics:
Optimizerx CorpShould Know
Financial Times Ranks OptimizeRx Amongst Americas' - Vimarsana News

Financial Times Ranks OptimizeRx Amongst Americas'

OptimizeRx grew 2021 revenue by 42% year-over-year, spotlighting the rapid growth from the convergence of technology and healthcare...

Brokerages Anticipate OptimizeRx Co. (NASDAQ:OPRX) Will Announce Earnings of $0.19 Per Share - Vimarsana News

Brokerages Anticipate OptimizeRx Co. (NASDAQ:OPRX) Will Announce Earnings of $0.19 Per Share

Analysts forecast that OptimizeRx Co. (NASDAQ:OPRX – Get Rating) will report earnings of $0.19 per share for the current quarter, Zacks reports. Three analysts have made estimates for OptimizeRx’s earnings. The lowest EPS estimate is $0.18 and the highest is $0.19. OptimizeRx reported earnings per share of $0.03 in the same quarter last year, which […]